menu
    • menu

    Company profile for Alvotech

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Alvotech is a privately owned, fully integrated specialty biopharmaceutical company focused exclusively on development and manufacturing of high quality biosimilar products. We are specialists in biogeneric product creation, all along the value chain from cell line development to commercial manufacturing. Our common goal: to be a global leader in the biosimilar space and to deliver high quality cost competitive products to pat...
    Alvotech is a privately owned, fully integrated specialty biopharmaceutical company focused exclusively on development and manufacturing of high quality biosimilar products. We are specialists in biogeneric product creation, all along the value chain from cell line development to commercial manufacturing. Our common goal: to be a global leader in the biosimilar space and to deliver high quality cost competitive products to patients worldwide. We come from all around the world, bringing literally thousands of years of combined knowledge and expertise to our mission.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AlvotechIceland Flag
    Country
    Country
    Iceland
    Address
    Address
    Sæmundargötu 15-19, 101 Reykjavík
    Telephone
    Telephone
    +354 522 2900
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.alvotech.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/alvotech
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/alvotech_bio

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Dr. Reddy's Receives EC Approval For AVT03: Biosimilar Launch
    Dr. Reddy's Receives EC Approval For AVT03: Biosimilar Launch

    24 Nov 2025

    // PRESS RELEASE

    https://www.drreddys.com/cms/sites/default/files/2025-11/DRL-finalpressrelease-24thNov2025-Deno.pdf

    PRESS RELEASE
    24 Nov 2025
    Share Share
    Alvotech Gets AVT03, Biosimilar Approval For Prolia And Xgeva
    Alvotech Gets AVT03, Biosimilar Approval For Prolia And Xgeva

    24 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/24/3193283/0/en/Alvotech-Announces-Approval-of-AVT03-a-Biosimilar-to-Prolia-and-Xgeva-denosumab-in-the-European-Economic-Area.html

    GLOBENEWSWIRE
    24 Nov 2025
    Share Share
    Alvotech USA's Ustekinumab Receives BLA Approval in US
    Alvotech USA's Ustekinumab Receives BLA Approval in US

    21 Nov 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761343

    FDA
    21 Nov 2025
    Share Share
    Alvotech, Advanz Pharma Gain EMA Nod for Gobivaz
    Alvotech, Advanz Pharma Gain EMA Nod for Gobivaz

    20 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-20/alvotech-and-advanz-pharma-receive-marketing-approval-across-the-european-economic-area-for-gobivaz-a-first-in-market-biosimilar-to-simponi-golimu

    PHARMIWEB
    20 Nov 2025
    Share Share
    Alvotech Reports 9-Month 2025 Results & Business Update
    Alvotech Reports 9-Month 2025 Results & Business Update

    12 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/12/3186850/0/en/Alvotech-Reports-Results-for-the-First-Nine-Months-of-2025-and-Provides-a-Business-Update.html

    GLOBENEWSWIRE
    12 Nov 2025
    Share Share
    FDA Issues Form 483 to Alvotech
    FDA Issues Form 483 to Alvotech

    06 Nov 2025

    // FDA

    https://www.fda.gov/media/189495/download

    FDA
    06 Nov 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search